LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,415,499
تعداد دریافت فایل اصل مقاله11,291,294
Soltan-Alinejad, Parisa, Alipour, Hamzeh, Meharabani, Davood, Azizi, Kourosh. (1401). Therapeutic Potential of Bee and Scorpion Venom Phospholipase A2 (PLA2): A Narrative Review. سامانه مدیریت نشریات علمی, 47(4), 300-313. doi: 10.30476/ijms.2021.88511.1927
Parisa Soltan-Alinejad; Hamzeh Alipour; Davood Meharabani; Kourosh Azizi. "Therapeutic Potential of Bee and Scorpion Venom Phospholipase A2 (PLA2): A Narrative Review". سامانه مدیریت نشریات علمی, 47, 4, 1401, 300-313. doi: 10.30476/ijms.2021.88511.1927
Soltan-Alinejad, Parisa, Alipour, Hamzeh, Meharabani, Davood, Azizi, Kourosh. (1401). 'Therapeutic Potential of Bee and Scorpion Venom Phospholipase A2 (PLA2): A Narrative Review', سامانه مدیریت نشریات علمی, 47(4), pp. 300-313. doi: 10.30476/ijms.2021.88511.1927
Soltan-Alinejad, Parisa, Alipour, Hamzeh, Meharabani, Davood, Azizi, Kourosh. Therapeutic Potential of Bee and Scorpion Venom Phospholipase A2 (PLA2): A Narrative Review. سامانه مدیریت نشریات علمی, 1401; 47(4): 300-313. doi: 10.30476/ijms.2021.88511.1927

Therapeutic Potential of Bee and Scorpion Venom Phospholipase A2 (PLA2): A Narrative Review

Iranian Journal of Medical Sciences
مقاله 3، دوره 47، شماره 4، مهر 2022، صفحه 300-313    اصل مقاله (269.47 K)
نوع مقاله: Review Article
شناسه دیجیتال (DOI): 10.30476/ijms.2021.88511.1927
نویسندگان
Parisa Soltan-Alinejad1؛ Hamzeh Alipour1؛ Davood Meharabani2، 3؛ Kourosh Azizi* 1
1Research Center for Health Sciences, Institute of Health, Department of Medical Entomology and Vector Control, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran
2Li Ka Shing Center for Health Research and Innovation, University of Alberta, Edmonton, AB, Canada
3Stem Cell Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Venomous arthropods such as scorpions and bees form one of the important groups with an essential role in medical entomology. Their venom possesses a mixture of diverse compounds, such as peptides, some of which have toxic effects, and enzymatic peptide Phospholipase A2 (PLA2) with a pharmacological potential in the treatment of a wide range of diseases. Bee and scorpion venom PLA2 group III has been used in immunotherapy, the treatment of neurodegenerative and inflammatory diseases. They were assessed for antinociceptive, wound healing, anti-cancer, anti-viral, anti-bacterial, anti-parasitic, and anti-angiogenesis effects. PLA2 has been identified in different species of scorpions and bees. The anti-leishmania, anti-bacterial, anti-viral, and anti-malarial activities of scorpion PLA2 still need further investigation. Many pieces of research have been stopped in the laboratory stage, and several studies need vast investigation in the clinical phase to show the pharmacological potential of PLA2. In this review, the medical significance of PLA2 from the venom of two arthropods, namely bees and scorpions, is discussed.
کلیدواژه‌ها
Scorpions؛ Bees؛ Phospholipases A2؛ Venoms
سایر فایل های مرتبط با مقاله
مراجع
  1. Jo M, Park MH, Kollipara PS, An BJ, Song HS, Han SB, et al. Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. Toxicol Appl Pharmacol. 2012;258:72-81. doi: 10.1016/j.taap.2011.10.009. PubMed PMID: 22027265.
  2. Mamelak AN, Jacoby DB. Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv. 2007;4:175-86. doi: 10.1517/17425247.4.2.175. PubMed PMID: 17335414.
  3. Remijsen Q, Verdonck F, Willems J. Parabutoporin, a cationic amphipathic peptide from scorpion venom: much more than an antibiotic. Toxicon. 2010;55:180-5. doi: 10.1016/j.toxicon.2009.10.027. PubMed PMID: 19874840.
  4. Hider RC. Honeybee venom: a rich source of pharmacologically active peptides. Endeavour. 1988;12:60-5. doi: 10.1016/0160-9327(88)90082-8. PubMed PMID: 2458907.
  5. Najafian M, Ghorbani A, Zargar M, Baradaran M, Baradaran N. Scorpion stings in pregnancy: an analysis of outcomes in 66 envenomed pregnant patients in Iran. J Venom Anim Toxins Incl Trop Dis. 2020;26:e20190039. doi: 10.1590/1678-9199-JVATITD-2019-0039. PubMed PMID: 32405289; PubMed Central PMCID: PMCPMC7204829.
  6. Lourenco WR. Scorpions and life-history strategies: from evolutionary dynamics toward the scorpionism problem. J Venom Anim Toxins Incl Trop Dis. 2018;24:19. doi: 10.1186/s40409-018-0160-0. PubMed PMID: 30158956; PubMed Central PMCID: PMCPMC6106892.
  7. Morgenstern D, Rohde BH, King GF, Tal T, Sher D, Zlotkin E. The tale of a resting gland: transcriptome of a replete venom gland from the scorpion Hottentotta judaicus. Toxicon. 2011;57:695-703. doi: 10.1016/j.toxicon.2011.02.001. PubMed PMID: 21329713.
  8. Al-Asmari AK, Islam M, Al-Zahrani AM. In vitro analysis of the anticancer properties of scorpion venom in colorectal and breast cancer cell lines. Oncol Lett. 2016;11:1256-62. doi: 10.3892/ol.2015.4036. PubMed PMID: 26893728; PubMed Central PMCID: PMCPMC4734223.
  9. Ding J, Chua PJ, Bay BH, Gopalakrishnakone P. Scorpion venoms as a potential source of novel cancer therapeutic compounds. Exp Biol Med (Maywood). 2014;239:387-93. doi: 10.1177/1535370213513991. PubMed PMID: 24599885.
  10. Mander L, Liu HW. Comprehensive natural products II: chemistry and biology. 1st ed. Amsterdam: Elsevier; 2010.
  11. Salem ML, Shoukry NM, Teleb WK, Abdel-Daim MM, Abdel-Rahman MA. In vitro and in vivo antitumor effects of the Egyptian scorpion Androctonus amoreuxi venom in an Ehrlich ascites tumor model. Springerplus. 2016;5:570. doi: 10.1186/s40064-016-2269-3. PubMed PMID: 27247867; PubMed Central PMCID: PMCPMC4864766.
  12. Tong-ngam P, Roytrakul S, Sritanaudomchai H. BmKn-2 scorpion venom peptide for killing oral cancer cells by apoptosis. Asian Pac J Cancer Prev. 2015;16:2807-11. doi: 10.7314/apjcp.2015.16.7.2807. PubMed PMID: 25854366.
  13. de la Salud Bea R, Petraglia AF, Ascuitto MR, Buck QM. Antibacterial Activity and Toxicity of Analogs of Scorpion Venom IsCT Peptides. Antibiotics (Basel). 2017;6. doi: 10.3390/antibiotics6030013. PubMed PMID: 28657596; PubMed Central PMCID: PMCPMC5617977.
  14. Hong W, Li T, Song Y, Zhang R, Zeng Z, Han S, et al. Inhibitory activity and mechanism of two scorpion venom peptides against herpes simplex virus type 1. Antiviral Res. 2014;102:1-10. doi: 10.1016/j.antiviral.2013.11.013. PubMed PMID: 24315793; PubMed Central PMCID: PMCPMC7113736.
  15. Gao B, Xu J, Rodriguez Mdel C, Lanz-Mendoza H, Hernandez-Rivas R, Du W, et al. Characterization of two linear cationic antimalarial peptides in the scorpion Mesobuthus eupeus. Biochimie. 2010;92:350-9. doi: 10.1016/j.biochi.2010.01.011. PubMed PMID: 20097251.
  16. Flores-Solis D, Toledano Y, Rodriguez-Lima O, Cano-Sanchez P, Ramirez-Cordero BE, Landa A, et al. Solution structure and antiparasitic activity of scorpine-like peptides from Hoffmannihadrurus gertschi. FEBS Lett. 2016;590:2286-96. doi: 10.1002/1873-3468.12255. PubMed PMID: 27314815.
  17. Dehong MFWSG. Antiepileptic effect of scorpion venom on SD rats with Epilepsy induced by kainic acid [J]. Heilongjiang Medicine and Pharmacy. 2002;6. 
  18. Araujo RL, Gomez MV. Potentiation of bradykinin action on smooth muscle by a scorpion venom extract. Gen Pharmacol. 1976;7:123-6. doi: 10.1016/0306-3623(76)90047-1. PubMed PMID: 976731.
  19. Hora ZA, Altaye SZ, Wubie AJ, Li J. Proteomics Improves the New Understanding of Honeybee Biology. J Agric Food Chem. 2018;66:3605-15. doi: 10.1021/acs.jafc.8b00772. PubMed PMID: 29558123.
  20. Son DJ, Lee JW, Lee YH, Song HS, Lee CK, Hong JT. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther. 2007;115:246-70. doi: 10.1016/j.pharmthera.2007.04.004. PubMed PMID: 17555825.
  21. Rady I, Siddiqui IA, Rady M, Mukhtar H. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett. 2017;402:16-31. doi: 10.1016/j.canlet.2017.05.010. PubMed PMID: 28536009; PubMed Central PMCID: PMCPMC5682937.
  22. Al-Ani I, Zimmermann S, Reichling J, Wink M. Pharmacological synergism of bee venom and melittin with antibiotics and plant secondary metabolites against multi-drug resistant microbial pathogens. Phytomedicine. 2015;22:245-55. doi: 10.1016/j.phymed.2014.11.019. PubMed PMID: 25765829.
  23. Zhou J, Zhao J, Zhang S, Shen J, Qi Y, Xue X, et al. Quantification of melittin and apamin in bee venom lyophilized powder from Apis mellifera by liquid chromatography-diode array detector-tandem mass spectrometry. Anal Biochem. 2010;404:171-8. doi: 10.1016/j.ab.2010.05.014. PubMed PMID: 20580685.
  24. Lee G, Bae H. Bee Venom Phospholipase A2: Yesterday’s Enemy Becomes Today’s Friend. Toxins (Basel). 2016;8:48. doi: 10.3390/toxins8020048. PubMed PMID: 26907347; PubMed Central PMCID: PMCPMC4773801.
  25. Varanda EA, Monti R, Tavares DC. Inhibitory effect of propolis and bee venom on the mutagenicity of some direct- and indirect-acting mutagens. Teratog Carcinog Mutagen. 1999;19:403-13. PubMed PMID: 10587410.
  26. Gajski G, Garaj-Vrhovac V. Radioprotective effects of honeybee venom (Apis mellifera) against 915-MHz microwave radiation-induced DNA damage in wistar rat lymphocytes: in vitro study. Int J Toxicol. 2009;28:88-98. doi: 10.1177/1091581809335051. PubMed PMID: 19482833.
  27. Lee JY, Kang SS, Kim JH, Bae CS, Choi SH. Inhibitory effect of whole bee venom in adjuvant-induced arthritis. In Vivo. 2005;19:801-5. PubMed PMID: 15999553.
  28. Baek YH, Huh JE, Lee JD, Choi DY, Park DS. Antinociceptive effect and the mechanism of bee venom acupuncture (Apipuncture) on inflammatory pain in the rat model of collagen-induced arthritis: Mediation by alpha2-Adrenoceptors. Brain Res. 2006;1073-1074:305-10. doi: 10.1016/j.brainres.2005.12.086. PubMed PMID: 16457792.
  29. Orsolic N, Sver L, Verstovsek S, Terzic S, Basic I. Inhibition of mammary carcinoma cell proliferation in vitro and tumor growth in vivo by bee venom. Toxicon. 2003;41:861-70. doi: 10.1016/s0041-0101(03)00045-x. PubMed PMID: 12782086.
  30. Orsolic N, Knezevic A, Sver L, Terzic S, Hackenberger BK, Basic I. Influence of honey bee products on transplantable murine tumours. Vet Comp Oncol. 2003;1:216-26. doi: 10.1111/j.1476-5810.2003.00029.x. PubMed PMID: 19379183.
  31. Li JH, Zhang CX, Shen LR, Tang ZH, Cheng JA. Expression and regulation of phospholipase A2 in venom gland of the chinese honeybee, Apis cerana cerana. Arch Insect Biochem Physiol. 2005;60:1-12. doi: 10.1002/arch.20075. PubMed PMID: 16116618.
  32. Kini RM. Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes. Toxicon. 2003;42:827-40. doi: 10.1016/j.toxicon.2003.11.002. PubMed PMID: 15019485.
  33. Sato H, Taketomi Y, Isogai Y, Miki Y, Yamamoto K, Masuda S, et al. Group III secreted phospholipase A2 regulates epididymal sperm maturation and fertility in mice. J Clin Invest. 2010;120:1400-14. doi: 10.1172/JCI40493. PubMed PMID: 20424323; PubMed Central PMCID: PMCPMC2860917.
  34. Sato H, Kato R, Isogai Y, Saka G, Ohtsuki M, Taketomi Y, et al. Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis. J Biol Chem. 2008;283:33483-97. doi: 10.1074/jbc.M804628200. PubMed PMID: 18801741; PubMed Central PMCID: PMCPMC2662271.
  35. Masuda S, Yamamoto K, Hirabayashi T, Ishikawa Y, Ishii T, Kudo I, et al. Human group III secreted phospholipase A2 promotes neuronal outgrowth and survival. Biochem J. 2008;409:429-38. doi: 10.1042/BJ20070844. PubMed PMID: 17868035.
  36. Valentin E, Ghomashchi F, Gelb MH, Lazdunski M, Lambeau G. Novel human secreted phospholipase A(2) with homology to the group III bee venom enzyme. J Biol Chem. 2000;275:7492-6. doi: 10.1074/jbc.275.11.7492. PubMed PMID: 10713052.
  37. Guerin V, Dubarryr M, Robic D, Brachet F, Rautureau M, Andre C, et al. Microsphere entrapped bee-venom phospholipase A2 retains specific IgE binding capacity: a possible use for oral specific immunotherapy. J Microencapsul. 2002;19:761-5. doi: 10.1080/02652040210162612. PubMed PMID: 12569024.
  38. Urbanek R, Kemeny DM, Richards D. Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy. Clin Allergy. 1986;16:317-22. doi: 10.1111/j.1365-2222.1986.tb01963.x. PubMed PMID: 3742787.
  39. Lichtenstein LM, Valentine MD, Sobotka AK. A case for venom treatment in anaphylactic sensitivity to hymenoptera sting. N Engl J Med. 1974;290:1223-7. doi: 10.1056/NEJM197405302902204. PubMed PMID: 4133096.
  40. Ozdemir C, Kucuksezer UC, Akdis M, Akdis CA. Mechanisms of immunotherapy to wasp and bee venom. Clin Exp Allergy. 2011;41:1226-34. doi: 10.1111/j.1365-2222.2011.03812.x. PubMed PMID: 21729181.
  41. Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med. 1978;299:157-61. doi: 10.1056/NEJM197807272990401. PubMed PMID: 78446.
  42. Muller U, Akdis CA, Fricker M, Akdis M, Blesken T, Bettens F, et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol. 1998;101:747-54. doi: 10.1016/S0091-6749(98)70402-6. PubMed PMID: 9648701.
  43. Akdis CA, Akdis M, Blesken T, Wymann D, Alkan SS, Muller U, et al. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest. 1996;98:1676-83. doi: 10.1172/JCI118963. PubMed PMID: 8833918; PubMed Central PMCID: PMCPMC507602.
  44. Irsch J, Konig C, Lohndorf A, Tesch H, Krieg T, Merk H, et al. The frequency of phospholipase A2 binding of basophilic granulocytes does not decrease during bee-venom-specific immunotherapy. Allergy. 1999;54:742-7. doi: 10.1034/j.1398-9995.1999.00952.x. PubMed PMID: 10442531.
  45. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057-61. doi: 10.1126/science.1079490. PubMed PMID: 12522256.
  46. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest. 1998;102:98-106. doi: 10.1172/JCI2250. PubMed PMID: 9649562; PubMed Central PMCID: PMCPMC509070.
  47. von Garnier C, Astori M, Kettner A, Dufour N, Heusser C, Corradin G, et al. Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis. Eur J Immunol. 2000;30:1638-45. doi: 10.1002/1521-4141(200006)30:6<1638:: AID-IMMU1638>3.0.CO;2-R. PubMed PMID: 10898500.
  48. Orsolic N. Bee venom in cancer therapy. Cancer Metastasis Rev. 2012;31:173-94. doi: 10.1007/s10555-011-9339-3. PubMed PMID: 22109081.
  49. Jang MH, Shin MC, Lim S, Han SM, Park HJ, Shin I, et al. Bee venom induces apoptosis and inhibits expression of cyclooxygenase-2 mRNA in human lung cancer cell line NCI-H1299. J Pharmacol Sci. 2003;91:95-104. doi: 10.1254/jphs.91.95. PubMed PMID: 12686753.
  50. Chaisakul J, Hodgson WC, Kuruppu S, Prasongsook N. Effects of Animal Venoms and Toxins on Hallmarks of Cancer. J Cancer. 2016;7:1571-8. doi: 10.7150/jca.15309. PubMed PMID: 27471574; PubMed Central PMCID: PMCPMC4964142.
  51. Nabiuni M, Safaeinejad Z, Parivar K, Divsalar A, Nazari Z. Antineoplastic effects of honey bee venom. Zahedan J Res Med Sci. 2013;15:1-5. 
  52. Kong GM, Tao WH, Diao YL, Fang PH, Wang JJ, Bo P, et al. Melittin induces human gastric cancer cell apoptosis via activation of mitochondrial pathway. World J Gastroenterol. 2016;22:3186-95. doi: 10.3748/wjg.v22.i11.3186. PubMed PMID: 27003995; PubMed Central PMCID: PMCPMC4789993.
  53. Gajski G, Garaj-Vrhovac V. Melittin: a lytic peptide with anticancer properties. Environ Toxicol Pharmacol. 2013;36:697-705. doi: 10.1016/j.etap.2013.06.009. PubMed PMID: 23892471.
  54. Hong SJ, Rim GS, Yang HI, Yin CS, Koh HG, Jang MH, et al. Bee venom induces apoptosis through caspase-3 activation in synovial fibroblasts of patients with rheumatoid arthritis. Toxicon. 2005;46:39-45. doi: 10.1016/j.toxicon.2005.03.015. PubMed PMID: 15922390.
  55. Moon DO, Park SY, Heo MS, Kim KC, Park C, Ko WS, et al. Key regulators in bee venom-induced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells through downregulation of ERK and Akt. Int Immunopharmacol. 2006;6:1796-807. doi: 10.1016/j.intimp.2006.07.027. PubMed PMID: 17052670.
  56. Cho HJ, Jeong YJ, Park KK, Park YY, Chung IK, Lee KG, et al. Bee venom suppresses PMA-mediated MMP-9 gene activation via JNK/p38 and NF-kappaB-dependent mechanisms. J Ethnopharmacol. 2010;127:662-8. doi: 10.1016/j.jep.2009.12.007. PubMed PMID: 19969058.
  57. Rahman KM, Sarkar FH, Banerjee S, Wang Z, Liao DJ, Hong X, et al. Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model. Mol Cancer Ther. 2006;5:2747-56. doi: 10.1158/1535-7163.MCT-06-0221. PubMed PMID: 17121921.
  58. Li B, Gu W, Zhang C, Huang XQ, Han KQ, Ling CQ. Growth arrest and apoptosis of the human hepatocellular carcinoma cell line BEL-7402 induced by melittin. Onkologie. 2006;29:367-71. doi: 10.1159/000094711. PubMed PMID: 16974113.
  59. Fletcher JE, Jiang MS. Possible mechanisms of action of cobra snake venom cardiotoxins and bee venom melittin. Toxicon. 1993;31:669-95. doi: 10.1016/0041-0101(93)90375-s. PubMed PMID: 8342168.
  60. Shier WT. Activation of high levels of endogenous phospholipase A2 in cultured cells. Proc Natl Acad Sci U S A. 1979;76:195-9. doi: 10.1073/pnas.76.1.195. PubMed PMID: 106389; PubMed Central PMCID: PMCPMC382904.
  61. Altinbas B, Topuz BB, Yilmaz MS, Aydin C, Savci V, Jochem J, et al. The mediation of the central histaminergic system in the pressor effect of intracerebroventricularly injected melittin, a phospholipase A2 activator, in normotensive rats. Prostaglandins Leukot Essent Fatty Acids. 2012;87:153-8. doi: 10.1016/j.plefa.2012.08.006. PubMed PMID: 22995146.
  62. Grandison L. Stimulation of anterior pituitary prolactin release by melittin, an activator of phospholipase A2. Endocrinology. 1984;114:1-7. doi: 10.1210/endo-114-1-1. PubMed PMID: 6418521.
  63. Lad PJ, Shier WT. Activation of microsomal guanylate cyclase by a cytotoxic polypeptide: melittin. Biochem Biophys Res Commun. 1979;89:315-21. doi: 10.1016/0006-291x(79)90980-x. PubMed PMID: 38790.
  64. Putz T, Ramoner R, Gander H, Rahm A, Bartsch G, Thurnher M. Antitumor action and immune activation through cooperation of bee venom secretory phospholipase A2 and phosphatidylinositol-(3,4)-bisphosphate. Cancer Immunol Immunother. 2006;55:1374-83. doi: 10.1007/s00262-006-0143-9. PubMed PMID: 16485125.
  65. Putz T, Ramoner R, Gander H, Rahm A, Bartsch G, Bernardo K, et al. Bee venom secretory phospholipase A2 and phosphatidylinositol-homologues cooperatively disrupt membrane integrity, abrogate signal transduction and inhibit proliferation of renal cancer cells. Cancer Immunol Immunother. 2007;56:627-40. doi: 10.1007/s00262-006-0220-0. PubMed PMID: 16947021.
  66. Brandner S, Klein MA, Frigg R, Pekarik V, Parizek P, Raeber A, et al. Neuroinvasion of prions: insights from mouse models. Exp Physiol. 2000;85:705-12. doi: 10.1111/j.1469-445x.2000.02091.x. PubMed PMID: 11187965.
  67. Sim VL. Prion disease: chemotherapeutic strategies. Infect Disord Drug Targets. 2012;12:144-60. doi: 10.2174/187152612800100161. PubMed PMID: 22420513.
  68. Kolko M, DeCoster MA, de Turco EB, Bazan NG. Synergy by secretory phospholipase A2 and glutamate on inducing cell death and sustained arachidonic acid metabolic changes in primary cortical neuronal cultures. J Biol Chem. 1996;271:32722-8. doi: 10.1074/jbc.271.51.32722. PubMed PMID: 8955105.
  69. Jeong JK, Moon MH, Bae BC, Lee YJ, Seol JW, Park SY. Bee venom phospholipase A2 prevents prion peptide induced-cell death in neuronal cells. Int J Mol Med. 2011;28:867-73. doi: 10.3892/ijmm.2011.730. PubMed PMID: 21701769.
  70. Ye M, Chung HS, Lee C, Yoon MS, Yu AR, Kim JS, et al. Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer’s disease. J Neuroinflammation. 2016;13:10. doi: 10.1186/s12974-016-0476-z. PubMed PMID: 26772975; PubMed Central PMCID: PMCPMC4715334.
  71. Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol. 2005;76:77-98. doi: 10.1016/j.pneurobio.2005.06.004. PubMed PMID: 16081203.
  72. Jana M, Palencia CA, Pahan K. Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer’s disease. J Immunol. 2008;181:7254-62. doi: 10.4049/jimmunol.181.10.7254. PubMed PMID: 18981147; PubMed Central PMCID: PMCPMC2701549.
  73. Muehlhauser F, Liebl U, Kuehl S, Walter S, Bertsch T, Fassbender K. Aggregation-Dependent interaction of the Alzheimer’s beta-amyloid and microglia. Clin Chem Lab Med. 2001;39:313-6. doi: 10.1515/CCLM.2001.048. PubMed PMID: 11388654.
  74. Baek H, Park SY, Ku SJ, Ryu K, Kim Y, Bae H, et al. Bee Venom Phospholipase A2 Induces Regulatory T Cell Populations by Suppressing Apoptotic Signaling Pathway. Toxins (Basel). 2020;12. doi: 10.3390/toxins12030198. PubMed PMID: 32235689; PubMed Central PMCID: PMCPMC7150970.
  75. Hirsch EC, Hunot S. Neuroinflammation in Parkinson’s disease: a target for neuroprotection? Lancet Neurol. 2009;8:382-97. doi: 10.1016/S1474-4422(09)70062-6. PubMed PMID: 19296921.
  76. Awad K, Abushouk AI, AbdelKarim AH, Mohammed M, Negida A, Shalash AS. Bee venom for the treatment of Parkinson’s disease: How far is it possible? Biomed Pharmacother. 2017;91:295-302. doi: 10.1016/j.biopha.2017.04.065. PubMed PMID: 28477460.
  77. Kim HW, Kwon YB, Han HJ, Yang IS, Beitz AJ, Lee JH. Antinociceptive mechanisms associated with diluted bee venom acupuncture (apipuncture) in the rat formalin test: involvement of descending adrenergic and serotonergic pathways. Pharmacol Res. 2005;51:183-8. doi: 10.1016/j.phrs.2004.07.011. PubMed PMID: 15629266.
  78. Olson KE, Gendelman HE. Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson’s disease. Curr Opin Pharmacol. 2016;26:87-95. doi: 10.1016/j.coph.2015.10.006. PubMed PMID: 26571205; PubMed Central PMCID: PMCPMC4716884.
  79. Doo AR, Kim SN, Kim ST, Park JY, Chung SH, Choe BY, et al. Bee venom protects SH-SY5Y human neuroblastoma cells from 1-methyl-4-phenylpyridinium-induced apoptotic cell death. Brain Res. 2012;1429:106-15. doi: 10.1016/j.brainres.2011.10.003. PubMed PMID: 22078207.
  80. Doo AR, Kim ST, Kim SN, Moon W, Yin CS, Chae Y, et al. Neuroprotective effects of bee venom pharmaceutical acupuncture in acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson’s disease. Neurol Res. 2010;32:88-91. doi: 10.1179/016164109X12537002794282. PubMed PMID: 20034453.
  81. Lee SM, Yang EJ, Choi SM, Kim SH, Baek MG, Jiang JH. Effects of bee venom on glutamate-induced toxicity in neuronal and glial cells. Evid Based Complement Alternat Med. 2012;2012:368196. doi: 10.1155/2012/368196. PubMed PMID: 21904562; PubMed Central PMCID: PMCPMC3166716.
  82. Kim KH, Lee SY, Shin J, Hwang JT, Jeon HN, Bae H. Dose-Dependent Neuroprotective Effect of Standardized Bee Venom Phospholipase A2 Against MPTP-Induced Parkinson’s Disease in Mice. Front Aging Neurosci. 2019;11:80. doi: 10.3389/fnagi.2019.00080. PubMed PMID: 31024294; PubMed Central PMCID: PMCPMC6462482.
  83. Ye M, Chung HS, Lee C, Hyun Song J, Shim I, Kim YS, et al. Bee venom phospholipase A2 ameliorates motor dysfunction and modulates microglia activation in Parkinson’s disease alpha-synuclein transgenic mice. Exp Mol Med. 2016;48:e244. doi: 10.1038/emm.2016.49. PubMed PMID: 27388550; PubMed Central PMCID: PMCPMC4973312.
  84. Chung ES, Lee G, Lee C, Ye M, Chung HS, Kim H, et al. Bee Venom Phospholipase A2, a Novel Foxp3+ Regulatory T Cell Inducer, Protects Dopaminergic Neurons by Modulating Neuroinflammatory Responses in a Mouse Model of Parkinson’s Disease. J Immunol. 2015;195:4853-60. doi: 10.4049/jimmunol.1500386. PubMed PMID: 26453752.
  85. Liu XD, Zhang JL, Zheng HG, Liu FY, Chen Y. Clinical randomized study of bee-sting therapy for rheumatoid arthritis. Zhen Ci Yan Jiu. 2008;33:197-200. PubMed PMID: 18807725.
  86. Lee JD, Park HJ, Chae Y, Lim S. An Overview of Bee Venom Acupuncture in the Treatment of Arthritis. Evid Based Complement Alternat Med. 2005;2:79-84. doi: 10.1093/ecam/neh070. PubMed PMID: 15841281; PubMed Central PMCID: PMCPMC1062163.
  87. Castro HJ, Mendez-Lnocencio JI, Omidvar B, Omidvar J, Santilli J, Nielsen HS, Jr., et al. A phase I study of the safety of honeybee venom extract as a possible treatment for patients with progressive forms of multiple sclerosis. Allergy Asthma Proc. 2005;26:470-6. PubMed PMID: 16541972.
  88. Shin D, Lee G, Sohn SH, Park S, Jung KH, Lee JM, et al. Regulatory T Cells Contribute to the Inhibition of Radiation-Induced Acute Lung Inflammation via Bee Venom Phospholipase A(2) in Mice. Toxins (Basel). 2016;8. doi: 10.3390/toxins8050131. PubMed PMID: 27144583; PubMed Central PMCID: PMCPMC4885046.
  89. Billingham ME, Morley J, Hanson JM, Shipolini RA, Vernon CA. Letter: An anti-inflammatory peptide from bee venom. Nature. 1973;245:163-4. doi: 10.1038/245163a0. PubMed PMID: 4582672.
  90. Im EJ, Kim SJ, Hong SB, Park JK, Rhee MH. Anti-Inflammatory Activity of Bee Venom in BV2 Microglial Cells: Mediation of MyD88-Dependent NF-kappaB Signaling Pathway. Evid Based Complement Alternat Med. 2016;2016:3704764. doi: 10.1155/2016/3704764. PubMed PMID: 27563334; PubMed Central PMCID: PMCPMC4987476.
  91. Kim H, Lee H, Lee G, Jang H, Kim SS, Yoon H, et al. Phospholipase A2 inhibits cisplatin-induced acute kidney injury by modulating regulatory T cells by the CD206 mannose receptor. Kidney Int. 2015;88:550-9. doi: 10.1038/ki.2015.147. PubMed PMID: 25993317.
  92. Hossen MS, Shapla UM, Gan SH, Khalil MI. Impact of Bee Venom Enzymes on Diseases and Immune Responses. Molecules. 2016;22. doi: 10.3390/molecules22010025. PubMed PMID: 28035985; PubMed Central PMCID: PMCPMC6155781.
  93. Lee G, Kang G-H, Bae H. Bee venom phospholipase A2 suppression of experimental autoimmune encephalomyelitis is dependent on its enzymatic activity. Molecular & Cellular Toxicology. 2019;15:307-13. doi: 10.1007/s13273-019-0034-8.
  94. Geha RS. Regulation of IgE synthesis in humans. J Allergy Clin Immunol. 1992;90:143-50. doi: 10.1016/0091-6749(92)90064-9. PubMed PMID: 1500620.
  95. Chung KF, Barnes PJ. Cytokines in asthma. Thorax. 1999;54:825-57. doi: 10.1136/thx.54.9.825. PubMed PMID: 10456976; PubMed Central PMCID: PMCPMC1745579.
  96. Mucida DS, de Castro Keller A, Fernvik EC, Russo M. Unconventional strategies for the suppression of allergic asthma. Curr Drug Targets Inflamm Allergy. 2003;2:187-95. doi: 10.2174/1568010033484223. PubMed PMID: 14561172.
  97. Park S, Baek H, Jung KH, Lee G, Lee H, Kang GH, et al. Bee venom phospholipase A2 suppresses allergic airway inflammation in an ovalbumin-induced asthma model through the induction of regulatory T cells. Immun Inflamm Dis. 2015;3:386-97. doi: 10.1002/iid3.76. PubMed PMID: 26734460; PubMed Central PMCID: PMCPMC4693726.
  98. Kim KH, Kim M, Lee J, Jeon HN, Kim SH, Bae H. Comparison of the Protective Effects of Bee Venom Extracts with Varying PLA2 Compositions in a Mouse Model of Parkinson’s Disease. Toxins (Basel). 2019;11. doi: 10.3390/toxins11060358. PubMed PMID: 31248167; PubMed Central PMCID: PMCPMC6628630.
  99. Baek H, Lee CJ, Choi DB, Kim NS, Kim YS, Ye YJ, et al. Bee venom phospholipase A2 ameliorates Alzheimer’s disease pathology in Abeta vaccination treatment without inducing neuro-inflammation in a 3xTg-AD mouse model. Sci Rep. 2018;8:17369. doi: 10.1038/s41598-018-35030-1. PubMed PMID: 30478329; PubMed Central PMCID: PMCPMC6255868.
  100. Chen CH, Zhou W, Liu S, Deng Y, Cai F, Tone M, et al. Increased NF-kappaB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer’s disease. Int J Neuropsychopharmacol. 2012;15:77-90. doi: 10.1017/S1461145711000149. PubMed PMID: 21329555.
  101. Ham HJ, Han SB, Yun J, Yeo IJ, Ham YW, Kim SH, et al. Bee venom phospholipase A2 ameliorates amyloidogenesis and neuroinflammation through inhibition of signal transducer and activator of transcription-3 pathway in Tg2576 mice. Transl Neurodegener. 2019;8:26. doi: 10.1186/s40035-019-0167-7. PubMed PMID: 31592103; PubMed Central PMCID: PMCPMC6774221.
  102. Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol. 2003;23:460-4. doi: 10.1016/s0270-9295(03)00089-5. PubMed PMID: 13680535. 
  103. Kim H, Keum DJ, Kwak J, Chung HS, Bae H. Bee venom phospholipase A2 protects against acetaminophen-induced acute liver injury by modulating regulatory T cells and IL-10 in mice. PLoS One. 2014;9:e114726. doi: 10.1371/journal.pone.0114726. PubMed PMID: 25478691; PubMed Central PMCID: PMCPMC4257707.
  104. Kang GH, Lee S, Choi DB, Shin D, Kim J, Yang H, et al. Bee Venom Phospholipase A2 Ameliorates Atherosclerosis by Modulating Regulatory T Cells. Toxins (Basel). 2020;12. doi: 10.3390/toxins12100609. PubMed PMID: 32977607; PubMed Central PMCID: PMCPMC7598180.
  105. Chen J, Lariviere WR. The nociceptive and anti-nociceptive effects of bee venom injection and therapy: a double-edged sword. Prog Neurobiol. 2010;92:151-83. doi: 10.1016/j.pneurobio.2010.06.006. PubMed PMID: 20558236; PubMed Central PMCID: PMCPMC2946189.
  106. Lee JH, Kwon YB, Han HJ, Mar WC, Lee HJ, Yang IS, et al. Bee venom pretreatment has both an antinociceptive and anti-inflammatory effect on carrageenan-induced inflammation. J Vet Med Sci. 2001;63:251-9. doi: 10.1292/jvms.63.251. PubMed PMID: 11307924.
  107. Alcindor T, Beauger N. Oxaliplatin: a review in the era of molecularly targeted therapy. Curr Oncol. 2011;18:18-25. doi: 10.3747/co.v18i1.708. PubMed PMID: 21331278; PubMed Central PMCID: PMCPMC3031353.
  108. Muggia FM. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers. Semin Oncol. 2004;31:17-24. doi: 10.1053/j.seminoncol.2004.11.007. PubMed PMID: 15726530.
  109. Petit T, Benider A, Yovine A, Bougnoux P, Spaeth D, Maindrault-Goebel F, et al. Phase II study of an oxaliplatin/vinorelbine combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer. Anticancer Drugs. 2006;17:337-43. doi: 10.1097/00001813-200603000-00013. PubMed PMID: 16520663.
  110. Li D, Kim W, Shin D, Jung Y, Bae H, Kim SK. Preventive Effects of Bee Venom Derived Phospholipase A(2) on Oxaliplatin-Induced Neuropathic Pain in Mice. Toxins (Basel). 2016;8. doi: 10.3390/toxins8010027. PubMed PMID: 26797636; PubMed Central PMCID: PMCPMC4728549.
  111. Nakashima A, Tomono S, Yamazaki T, Inui M, Morita N, Ichimonji I, et al. Phospholipase A2 from bee venom increases poly(I:C)-induced activation in human keratinocytes. Int Immunol. 2020;32:371-83. doi: 10.1093/intimm/dxaa005. PubMed PMID: 31957789.
  112. Brown S, Reynolds NJ. Atopic and non-atopic eczema. BMJ. 2006;332:584-8. doi: 10.1136/bmj.332.7541.584. PubMed PMID: 16528081; PubMed Central PMCID: PMCPMC1397720.
  113. Jung KH, Baek H, Kang M, Kim N, Lee SY, Bae H. Bee Venom Phospholipase A2 Ameliorates House Dust Mite Extract Induced Atopic Dermatitis Like Skin Lesions in Mice. Toxins (Basel). 2017;9. doi: 10.3390/toxins9020068. PubMed PMID: 28218721; PubMed Central PMCID: PMCPMC5331447.
  114. Shin D, Choi W, Bae H. Bee Venom Phospholipase A2 Alleviate House Dust Mite-Induced Atopic Dermatitis-Like Skin Lesions by the CD206 Mannose Receptor. Toxins (Basel). 2018;10. doi: 10.3390/toxins10040146. PubMed PMID: 29614845; PubMed Central PMCID: PMCPMC5923312.
  115. Hewawaduge C, Lee B-H, Kim T-H, Uddin MB, Kim J-H, Kim CG, et al. Phospholipase A2 isolated from the venom of honey bees prevents viral attachment in mammalian cells. Journal of Biomedical and Translational Research. 2016;17:75-8. doi: 10.12729/jbtr.2016.17.3.075.
  116. Fenard D, Lambeau G, Maurin T, Lefebvre JC, Doglio A. A peptide derived from bee venom-secreted phospholipase A2 inhibits replication of T-cell tropic HIV-1 strains via interaction with the CXCR4 chemokine receptor. Mol Pharmacol. 2001;60:341-7. doi: 10.1124/mol.60.2.341. PubMed PMID: 11455021.
  117. Boulanger N, Brun R, Ehret-Sabatier L, Kunz C, Bulet P. Immunopeptides in the defense reactions of Glossina morsitans to bacterial and Trypanosoma brucei brucei infections. Insect Biochem Mol Biol. 2002;32:369-75. doi: 10.1016/s0965-1748(02)00029-2. PubMed PMID: 11886771.
  118. Boutrin MC, Foster HA, Pentreath VW. The effects of bee (Apis mellifera) venom phospholipase A2 on Trypanosoma brucei brucei and enterobacteria. Exp Parasitol. 2008;119:246-51. doi: 10.1016/j.exppara.2008.02.002. PubMed PMID: 18343372.
  119. Perumal Samy R, Gopalakrishnakone P, Thwin MM, Chow TK, Bow H, Yap EH, et al. Antibacterial activity of snake, scorpion and bee venoms: a comparison with purified venom phospholipase A2 enzymes. J Appl Microbiol. 2007;102:650-9. doi: 10.1111/j.1365-2672.2006.03161.x. PubMed PMID: 17309613.
  120. Moreira LA, Ito J, Ghosh A, Devenport M, Zieler H, Abraham EG, et al. Bee venom phospholipase inhibits malaria parasite development in transgenic mosquitoes. J Biol Chem. 2002;277:40839-43. doi: 10.1074/jbc.M206647200. PubMed PMID: 12167627.
  121. Deregnaucourt C, Schrevel J. Bee venom phospholipase A2 induces stage-specific growth arrest of the intraerythrocytic Plasmodium falciparum via modifications of human serum components. J Biol Chem. 2000;275:39973-80. doi: 10.1074/jbc.M006712200. PubMed PMID: 10988294.
  122. Hirsch EC, Breidert T, Rousselet E, Hunot S, Hartmann A, Michel PP. The role of glial reaction and inflammation in Parkinson’s disease. Ann N Y Acad Sci. 2003;991:214-28. doi: 10.1111/j.1749-6632.2003.tb07478.x. PubMed PMID: 12846989.
  123. Incamnoi P, Patramanon R, Thammasirirak S, Chaveerach A, Uawonggul N, Sukprasert S, et al. Heteromtoxin (HmTx), a novel heterodimeric phospholipase A(2) from Heterometrus laoticus scorpion venom. Toxicon. 2013;61:62-71. doi: 10.1016/j.toxicon.2012.10.012. PubMed PMID: 23142507.
  124. Jridi I, Catacchio I, Majdoub H, Shahbazeddah D, El Ayeb M, Frassanito MA, et al. Hemilipin, a novel Hemiscorpius lepturus venom heterodimeric phospholipase A2, which inhibits angiogenesis in vitro and in vivo. Toxicon. 2015;105:34-44. doi: 10.1016/j.toxicon.2015.08.022. PubMed PMID: 26335363.
  125. Jridi I, Catacchio I, Majdoub H, Shahbazzadeh D, El Ayeb M, Frassanito MA, et al. The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein. Toxicon. 2017;126:38-46. doi: 10.1016/j.toxicon.2016.12.001. PubMed PMID: 27940138.
  126. Zamudio FZ, Conde R, Arevalo C, Becerril B, Martin BM, Valdivia HH, et al. The mechanism of inhibition of ryanodine receptor channels by imperatoxin I, a heterodimeric protein from the scorpion Pandinus imperator. J Biol Chem. 1997;272:11886-94. doi: 10.1074/jbc.272.18.11886. PubMed PMID: 9115249.
  127. Conde R, Zamudio FZ, Becerril B, Possani LD. Phospholipin, a novel heterodimeric phospholipase A2 from Pandinus imperator scp6pion venom. FEBS Lett. 1999;460:447-50. doi: 10.1016/s0014-5793(99)01392-7. PubMed PMID: 10556514.
  128. Valdez-Cruz NA, Batista CV, Possani LD. Phaiodactylipin, a glycosylated heterodimeric phospholipase A from the venom of the scorpion Anuroctonus phaiodactylus. Eur J Biochem. 2004;271:1453-64. doi: 10.1111/j.1432-1033.2004.04047.x. PubMed PMID: 15066171.
  129. Louati H, Krayem N, Fendri A, Aissa I, Sellami M, Bezzine S, et al. A thermoactive secreted phospholipase A(2) purified from the venom glands of Scorpio maurus: relation between the kinetic properties and the hemolytic activity. Toxicon. 2013;72:133-42. doi: 10.1016/j.toxicon.2013.06.017. PubMed PMID: 23831286.
  130. Ramanaiah M, Parthasarathy PR, Venkaiah B. Purification and properties of phospholipase A2 from the venom of scorpion, (Heterometrus fulvipes). Biochem Int. 1990;20:931-40. PubMed PMID: 2112384.
  131. Iruela-Arispe ML, Zovein A. 8 - Angiogenesis. In: Polin RA, Abman SH, Rowitch DH, Benitz WE, Fox WW, editors. Fetal and Neonatal Physiology. 5th ed. Amsterdam: Elsevier; 2017. p. 85-9.e2. doi: 10.1016/B978-0-323-35214-7.00008-1.
  132. Krayem N, Abdelkefi-Koubaa Z, Marrakchi N, Luis J, Gargouri Y. Anti-angiogenic effect of phospholipases A2 from Scorpio maurus venom glands on Human Umbilical Vein Endothelial Cells. Toxicon. 2018;145:6-14. doi: 10.1016/j.toxicon.2018.02.042. PubMed PMID: 29486161.
  133. Lee YS, Kim YH, Shin EK, Kim DH, Lim SS, Lee JY, et al. Anti-angiogenic activity of methanol extract of Phellinus linteus and its fractions. J Ethnopharmacol. 2010;131:56-62. doi: 10.1016/j.jep.2010.05.064. PubMed PMID: 20554007.
  134. Krayem N, Abdelkefi-Koubaa Z, Marrakchi N, Gargouri Y, Luis J. Native and recombinant phospholipases A2 of Scorpio maurus venom glands impair angiogenesis by targeting integrins alpha5beta1 and alphavbeta3. Int J Biol Macromol. 2018;116:305-15. doi: 10.1016/j.ijbiomac.2018.04.141. PubMed PMID: 29715557.
  135. Vetter RS, Visscher PK. Bites and stings of medically important venomous arthropods. Int J Dermatol. 1998;37:481-96. doi: 10.1046/j.1365-4362.1998.00455.x. PubMed PMID: 9679688.
آمار
تعداد مشاهده مقاله: 5,462
تعداد دریافت فایل اصل مقاله: 3,366


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب